[{"orgOrder":0,"company":"Orkla","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"SWEDEN","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Salicylic Acid","moa":"COX-1","graph1":"Podiatry","graph2":"Undisclosed","graph3":"Orkla","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Solution","sponsorNew":"Orkla \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Orkla \/ Undisclosed"},{"orgOrder":0,"company":"New Horizon Medical Solutions","sponsor":"Amarex Clinical Research","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"","productType":"Cell & Gene Therapy","year":"2025","type":"Inapplicable","leadProduct":"Amnio Matrix","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"New Horizon Medical Solutions","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"New Horizon Medical Solutions \/ Amarex Clinical Research","highestDevelopmentStatusID":"1","companyTruncated":"New Horizon Medical Solutions \/ Amarex Clinical Research"},{"orgOrder":0,"company":"Changi General Hospital","sponsor":"ELO Water Pte. Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"SINGAPORE","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Elo Water","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"Changi General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Changi General Hospital \/ ELO Water Pte. Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Changi General Hospital \/ ELO Water Pte. Ltd."},{"orgOrder":0,"company":"The First Affiliated Hospital with Nanjing Medical University","sponsor":"Shandong Qilu Stem Cells Engineering Co., Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"CHINA","productType":"Cell & Gene Therapy","year":"2023","type":"Inapplicable","leadProduct":"Human Cord Blood Mononuclear Cell","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"The First Affiliated Hospital with Nanjing Medical University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Injection","sponsorNew":"The First Affiliated Hospital with Nanjing Medical University \/ Shandong Qilu Stem Cells Engineering Co., Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"The First Affiliated Hospital with Nanjing Medical University \/ Shandong Qilu Stem Cells Engineering Co., Ltd."},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"SOUTH KOREA","productType":"Peptide, Unconjugated","year":"2024","type":"Inapplicable","leadProduct":"Marine Collagen Peptides","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"The VA Western New York Healthcare System","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"U.S.A","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Procenta","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"The VA Western New York Healthcare System","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Dressing","sponsorNew":"The VA Western New York Healthcare System \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"The VA Western New York Healthcare System \/ Undisclosed"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check COS database
Check USDMF database

Contact Us
PharmaScopic.com

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

New Horizon Medical Solutions

Country

BioJapan

Not Confirmed

02

TCI Co., Ltd.

Country

BioJapan

Not Confirmed

03

The First Affiliated Hospital with Nanjing Medical University

Country

BioJapan

Not Confirmed

04

Changi General Hospital

Country

BioJapan

Not Confirmed

05

The VA Western New York Healthcare System

Country

BioJapan

Not Confirmed

06

Oneness Biotech

Taiwan

BioJapan

Not Confirmed

07

Orkla

Sweden

BioJapan

Not Confirmed

08

PolarityTE

U.S.A

BioJapan

Not Confirmed